Diabetes risk and oxidative and proinflammatory status in obese adolescents according to exercise dose: a randomized controlled trial by Catarina Maria Sousa Neves
2014/2015
Catarina Maria Sousa Neves
Diabetes risk and oxidative and 
proinflammatory status in obese 
adolescents according to exercise 
dose: a randomized controlled trial
março, 2015
Mestrado Integrado em Medicina
Área: Pediatria
Tipologia: Dissertação
Trabalho efetuado sob a Orientação de:
Dr.ª Carla Maria Barreto da Silva de Sousa Rego
E sob a Coorientação de:
Dr. Luís Filipe Barbosa Amado Belo
Trabalho organizado de acordo com as normas da revista:
Annals of Human Biology
Catarina Maria Sousa Neves
Diabetes risk and oxidative and 
proinflammatory status in obese 
adolescents according to exercise 
dose: a randomized controlled trial
março, 2015


  
 
 
 
 
 
 
To my dear parents 
Cândida e José Neves 
and my brother Miguel 
INDEX 
 
TITLE            3 
ABSTRACT           4 
INTRODUCTION          5 
METHODS           8 
Procedure and exercise interventions      9 
Outcomes 
1 - Anthropometric and nutritional status    10 
2 - Body composition       10 
3 - Pubertal stage        11 
4 - Biochemical analyses       11 
5 - Cardiorrespiratory fitness (CRF)     12 
Statistical Analyses        13 
RESULTS           14 
DISCUSSION          16 
CONCLUSION          21 
ACKNOWLEDGEMENTS         22 
REFERENCES          23 
  
2 
 
LIST OF ABBREVIATIONS AND ACRONYMS 
 
BMI - Body mass index 
BMI z-sc - Age- and sex-standardized Body Mass Index 
BFM – Body Fat Mass 
CRF - Cardiorespiratory fitness 
CRP - C-reactive protein 
CVD - Cardiovascular disease 
FFM – Fat Free Mass 
FPG - Fasting plasma glucose 
FPI - Fasting plasma insulin 
HDL-c - High-density lipoprotein cholesterol 
HOMA-IR - Homeostatic model assessment for insulin resistance 
IR - Insulin Resistance 
LDL-c - Low-density lipoprotein cholesterol 
MS - Metabolic Syndrome 
MVPA - Moderate-to-vigorous physical activity 
ox-LDL - oxidized-Low-density lipoprotein 
PA -Physical Activity 
T2DM - Type 2 Diabetes Mellitus 
TC – Total cholesterol 
TG - Triglycerides 
WC – Waist circumference 
WtHR – Waist to Height Ratio  
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ABSTRACT 
BACKGROUND Beside physical activity (PA) is crucial on prevention and treatment of 
pediatric obesity, there was a lack of consensus regarding the amount needed to improve 
body composition as also to reduce obesity related comorbidities. 
AIM To test dose-response of an exercise intervention program with moderate-to-vigorous 
PA (MVPA) on several features: body composition, insulin resistance, oxidative stress, 
proinflammatory status and cardiorespiratory fitness (CRF). 
SUBJECTS AND METHODS Obese adolescents (10-12 y) were recruited from a school 
(IG; n=34) and perform 3 times-week soccer and other activities; a control group (CG; 
n=10) performed no exercise other than curricular physical education. Baseline and post-
intervention (after 6 months) measures were made including anthropometry, body 
composition, lipid profile, glucose and insulin metabolism, oxidative stress and pro-
inflammatory status and CRF.  
RESULTS MVPA performed by IG showed significate positive effects in BMI-z-score, 
waist circumference, WtHR, body fat mass and free-fat mass. Besides, there was also an 
improvement in lipid profile (p<0.05), oxidized low-density lipoprotein (p<0.001), 
adiponectin (p<0.001) and CRF (p<0.001). There were no significant differences after 
intervention in C-Reactive Protein and HOMA-IR. Increased CRF was correlated with 
decreased adiposity markers and as also Low- density lipoprotein cholesterol, oxidized 
low-density lipoprotein and increased adiponectin. 
CONCLUSION An extra-curricular PA program with at least three times a week is effective 
in order to reduce co-morbidities related to obesity in youth population, principally 
cardiometabolic risk and oxidative and proinfllamatory status. 
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INTRODUCTION 
Childhood obesity is considered a growing global epidemic (Wang, 2004). The prevalence 
has rapidly increased worldwide and about 110 million children are classified as being 
overweight or obese (Cali and Caprio, 2008). In the European region, prevalence of 
pediatric obesity is also increasing, being Portugal on the top 5 of the highest prevalence 
(Livingstone, 2001, Wijnhoven et al., 2014). Moreover, a recent study reported that 19.7% 
of portuguese children are classified as being overweight and 8.2% as being obese, which 
is an alarming situation for this population in Portugal (Bingham et al., 2013). 
Overweight and obese children are expected to remain obese in adult life and are at great 
risk of developing cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM) 
(DeBoer, 2013, Zimmet et al., 2007). The most involved co-morbidities in obese 
adolescents are the metabolic syndrome (MS), hypertension, dyslipidemia, prediabetes, 
ovarian hyperandrogenism and non-alcoholic fatty liver disease/non-alcoholic steato-
hepatitis (Sypniewska, 2015, Morandi and Maffeis, 2014). It is important to identify 
metabolic complications in obese adolescents because these are at greater risk of 
developing a worse cardiometabolic prognosis compared to obese adolescents without 
metabolic impairments. However, if either obesity or MS resolves before adulthood this 
prognosis is no longer established (Morandi and Maffeis, 2014). 
Insulin Resistance (IR) is commonly observed on obesity and is deeply associated with 
the etiology of hypertension, coronary heart disease and T2DM (Lee and Kim, 2013). 
Diabetes risk and CVD are associated with prediabetes, which comprises impaired fasting 
glucose and/or impaired glucose tolerance, measures of IR (Li et al., 2009). This condition 
is associated with an increased lipid accumulation in visceral compartments, liver and 
muscle tissues and by a gradual fail in β-cell function with loss of sensibility to insulin 
6 
 
secretion. Epidemiology shows a parallel increased prevalence of prediabetes and T2DM 
and the progression of one to another has proven to be faster in obese children 
comparatively to adults (D'Adamo and Caprio, 2011). This progression represents a 
gradual deterioration in glucose-stimulated insulin response (Cali and Caprio, 2008). As 
what concerns to MS, also called IR syndrome, a real consensus about its definition in the 
adolescent population does not exist but it is known that the principal component of MS, 
waist measurement, is an independent predictor of IR (Morandi and Maffeis, 2014, 
Zimmet et al., 2007). Systemic inflammation is linked to obesity and it was demonstrated 
that the visceral adipocytes play an important role in the inflammatory process. The 
excess of visceral adipose tissue will determine a consistent low-grade degree of 
inflammation, which worsens when central obesity increases. Moreover, it is important to 
underline that science and clinical evidence has shown an independent association 
between obesity-related inflammation and IR as well as the risk of developing T2DM 
(DeBoer, 2013). 
There is a complex process linking IR to proinflammatory status and it appears to involve 
increases in oxidative stress in target tissues (DeBoer, 2013). Oxidative stress occurs 
when there is an unbalance between the production of reactive oxygen species and their 
clearance by endogenous antioxidants. ROS cause mitochondrial DNA damage which is 
importantly connected with obesity-related IR and the early pathophysiology of T2DM 
(Balagopal et al., 2011, D'Adamo and Caprio, 2011). 
Regular physical activity (PA) is an important weapon in the treatment of obesity because 
it decreases body adiposity, increases lean mass, improves cardiovascular fitness, blood 
lipid profile and enhances psychosocial well-being (Riddell and Iscoe, 2006). Moreover, 
physical exercise is known to exert independent positive effects on both inflammatory and 
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oxidative homeostasis (Oliver et al., 2010). Besides those benefits, PA also has an 
“insulin-like” effect, facilitating the transport of glucose from the blood to the muscle 
through the increase in GLUT-4 concentration and thus managing a control in blood 
glucose levels. It is important that the PA recommended is regular, as the insulin sensitivity 
decreases at the end of the exercise (Lee and Kim, 2013). However, it is not well known 
if exercise alone results in improving insulin sensibility (Lee and Kim, 2013). Presently, 
there are few randomized controlled trials that relate the impact of exercise dose on 
glucose tolerance in obese adolescents. Furthermore, many studies fail to contemplate 
the pubertal stage, which is very important considering that IR occurs with puberty (Lee 
and Kim, 2013). 
The purpose of this trial was to test the dose response effect of an exercise intervention 
program on IR, oxidative stress and proinflammatory status in obese adolescents. A 
secondary objective was to access the level of cardiorespiratory fitness and to correlate 
this variable with the aforementioned. 
  
8 
 
METHODS 
This trial involved adolescents recruited for a soccer intervention program named “Soccer 
as a novel therapeutic approach to pediatric obesity. A randomized controlled trial and its 
effects on fitness, body composition, cardiometabolic and oxidative markers” sponsored 
by UEFA. It was a prospective controlled randomized trial, conducted from September 
2013 to March 2014. 
Inclusion criteria were age from 10 to 12 years old (including children who turned 10 years 
in 2014), male gender and body-mass index (BMI) ≥ 85th percentile for age and gender - 
according to WHO cut-off values (de Onis et al., 2007). Exclusion criteria were being on 
a weight loss program with or without exercise in the last year, being under medication or 
having any severe medical condition - CVD, type I diabetes mellitus, endocrine or hepatic 
disease. 
Studied population were invited from a school in Perafita. A total of 65 adolescents were 
enrolled and 45 (69.2%) accepted to participate (Intervention Group - IG). The control 
group (CG) were 20 obese adolescents, matched for age and gender, which were 
alleatory selected from a pediatric obesity clinic in Porto city. The selection criteria were 
the absence of participation in any extra-school PA. 
Agreement and written informed consent were obtained by all children and parents. The 
participants were treated with full respect and privacy, and the study coordinators were 
trained before the start of the activities. The study was previously approved by the Faculty 
of Sport of Porto University Ethics Committee and followed the Declaration of Helsinki 
(2000) principles.  
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Procedure and exercise interventions 
IG was randomly separated into two different training groups: a soccer program group 
(SG) and a traditional activity program group (AG). Both groups had training sessions 3 
days per week, coordinated by teachers from Faculty of Sport of Porto University. SG 
consisted in a warm-up (10-20 min), different technical exercises and small-sided games 
(40-60 min) and a cool-down (10 min). AG included a warm-up (10-20 min), different 
activities such as strength and coordination exercises, walking and running (40-50 min) 
and a cool-down (10 min). Training intensities for the IG were designed to maintain heart 
rates at approximately 70-80% of maximum confirmed by monitoring (Polar Team 2 Pro 
System, Polar Electro, Kempele, Finland). All intervention sessions were conducted by 
two physical education teachers under the guidance of the principal investigator. 
Intensity of PA in SG and AG was measured during the first month of the trial, twice a 
week, using an ActiGraph accelerometer, model GT3X (Pensacola, FL USA). Percentage 
of Moderate-to-vigorous physical activity (MVPA) showed no significant differences 
between AG and SG (36.20% and 35.20% respectively). It was used a t Test in this 
statistical analyses with a p value of 0.667. Therefore, both groups were studied as one - 
IG.  
The CG consisted in adolescents who had no exercise interventions but the normal school 
mandatory physical activities (2 classes per week, 45-90 min each). 
Outcomes 
All measurements were made at baseline (before randomization) and 6 months after (at 
the end of the intervention). Assessments were done under similar conditions and at 
approximately the same time of the day to minimize potential diurnal variation in measured 
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variables. From the study protocol which included several variables, it was selected for 
this study the following: anthropometric and nutritional status, body composition, pubertal 
stage, biochemical analyses and cardiorespiratory fitness. 
 
1 - Anthropometric and nutritional status 
All anthropometric measurements were accessed according to both methodology and 
techniques internationally suggested (Jelliffe, 1989) and were made with every participant 
being on underwear and barefoot.  
Body mass evaluation was achieved using a physician’s digital scale (Tanita®, BC-418MA, 
USA) with results expressed in kilograms, and height values were obtained through a fixed 
stadiometer (Holtain Ltd., UK), with results expressed in meters. BMI values were 
calculated and expressed in kilograms per square meter and z-score values for BMI (BMI 
z-sc) were obtained with WHO AnthroPlus® software (WHO anthro). Excess weight and 
obesity were defined as a z-score value equal or higher than 1.0364 (85th percentile) and 
1.6449 (95th percentile) respectively. 
Waist circumference (WC) was measured with a metallic tape (Holtain, Lda) on bare skin 
at the umbilical level and the ratio between WC and height (WtHR) was calculated. WtHR 
greater than 0.50 was defined as a predictor of increased cardiometabolic risk (McCarthy 
and Ashwell, 2006). 
 
2 - Body composition 
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Body composition was accessed by dual-energy X-ray absorptiometry (DXA) (Hologic 
QDR 4500A, Hologic Inc., Waltham, MA, USA). The unit was calibrated according to 
manufacturer instructions and a trained technician did all exams. Percentage for body fat 
mass (%BFM) and fat-free mass (%FFM) were measured. 
 
3 - Pubertal stage 
Pubertal stage, an indicator of biological maturity, was characterized through a clinical 
evaluation of the secondary sex characteristics by an experienced pediatrician. The 
adolescents were stratified as: Tanner 1 - prepubertal, Tanner 2 and 3 - medium puberty, 
and Tanner 4 and 5 - final puberty, according to Tanner scale (Tanner, 1986). 
 
4 - Biochemical analyses 
Blood samples were collected by venipuncture in EDTA containing tubes after an 
overnight fasting (8-10h) and processed within 2 h of collection. This procedure was made 
to all the participants at baseline and after 6 months. Aliquots of plasma were stored at -
80oC until assayed. 
The variables determined from the blood samples were total cholesterol (TC), high-density 
lipoprotein cholesterol (HDL-c), triglycerides (TG), fasting plasma glucose (FPG), fasting 
plasma insulin (FPI), oxidized low-density lipoprotein (ox-LDL), adiponectin and plasma 
levels of C-reactive protein (CRP). 
TC, TG and HDL-c were determined by enzymatic colorimetric tests CHOD-PAP, GPO-
PAP and Direct HDL cholesterol methods, respectively. Low-density lipoprotein 
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cholesterol (LDL-c) was calculated with the Friedewald formula (Friedewald et al., 1972). 
High cardiometabolic risk was defined as TC ≥ 200 mg/dL, TG ≥ 150 mg/dL, LDL-c ≥ 130 
mg/dL and HDL-c ≤ 35 mg/dL, this score corresponds to the 95th percentile score for TC, 
TG and LDL-c and the 5th percentile for the HDL-c (Gidding et al., 2005). 
FPG and FPI were obtained through routine automated technology (Roche). Insulin 
resistance was measured by Homeostatic model assessment for insulin resistance 
(HOMA-IR), calculated as the product of the FPI (µU/ml) and the FPG (mg/dL) divided by 
405 (Matthews et al., 1985). IR was defined for HOMA-IR values equal or greater than 
2.67 and 5.22 for pre- and pubertal adolescents, respectively (Kurtoglu et al., 2010). Pre-
diabetes risk was determined by FPG ≥ 100 and < 126 mg/dL (Lee and Kim, 2013). 
ox-LDL (Mercodia) and adiponectin (eBioscience) were evaluated by commercial 
enzyme-linked immunoassays (ELISA). CRP was evaluated by immunoturbidimetry using 
commercially kits (CRP latex High-Sensitivity, Roche Diagnostics). 
 
5 - Cardiorrespiratory fitness (CRF) 
A progressive treadmill exercise test was used to estimate maximal oxygen uptake 
(VO2max). Boys walked/ran until exhaustion following a standardized protocol (Eiberg et 
al., 2005a, Eiberg et al., 2005b). The test started at 4 km/h without inclination and was 
maintained for 3 min to permit adaptation to the treadmill. After 3 min, the speed was 
increased to 8 km/h. After 5 min, the inclination was raised to 3% and then to 6% and 9% 
after 7 and 9 min, respectively. If children were able to endure more, the speed was 
increased to 9 km/h after 10 min and then 10 km/h after 13 min. Criteria for VO₂max 
included two of the following: (1) maximum heart rate >200 beats/min; (2) respiratory 
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exchange ratio (ratio of maximum carbon dioxide to VO2) >1.0; and (3) a plateau in oxygen 
consumption. The cut-off value used to define low CRF was 43.6 mlO2/min/Kg (Adegboye 
et al., 2011). 
 
Statistical Analyses 
Descriptive data are presented as mean and standard deviations for CG and IG at 
baseline and 6 months post-intervention, except for the metabolic variables FPI, HOMA-
IR and CRP which were presented as median and interquartile range as these showed 
deviation from normal distribution (Kolmogorov-Smirnov normality test). It was used a 
paired-samples Student’s t-test (for variables with a normal distribution) and a Wilcoxon 
signed-rank test (for variables without normal distribution) for longitudinal analysis. 
Correlations between studied variables were established by a Pearson’s or Spearman’s 
rank test as appropriate. 
Statistical analyses were conducted using SPSS version 22.0. Statistical significance was 
accepted at p less than 0.05. 
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RESULTS 
Characteristics of the study sample are presented in Table I. Only 10 out of 20 controls in 
CG and 34 out of 45 participants in the IG have completed both measurements (baseline 
and after 6 months). Subjects with only one measurement (baseline or post-intervention) 
were included as there was no difference in the various outcomes when comparing to the 
remaining subjects (data not shown). 
All of them were male, aged between 10 and 12 years old (mean of 10.7±1.3 years) and 
more than half were classified as being at a medium-phase of puberty (61.4% in Tanner 
stage 2-3). 
As what concerns to nutritional status and body composition, all of them were obese (BMI 
z-sc of 2.5±0.7; min: 1.8, max: 3.2) with no statistical difference between groups at 
baseline. The IG showed a significant decrease in BMI z-sc, WC, WtHR, %BFM and an 
increase in %FFM after intervention. Differently, in the CG presented a significant increase 
in %BFM (p=0.047) but no changes in %FFM. Besides the high cardiovascular risk 
according to WtHR observed in both groups even after intervention, the IG showed a 
significant decrease (Table I). 
Regarding metabolic variables, a significant improvement was observed on TC, TG, LDL-
c in the IG, after 6 months-intervention. Considering glucose and insulin metabolism, a 
decrease in HOMA-IR in IG and an increase in CG were observed after 6 months 
intervention, although without statistical significance. When referring to oxidative and 
proinflammatory status, it was observed a significant improvement in adiponectin and a 
reduction in ox-LDL in IG but no significant differences in CRP. 
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As for the CRF, there was an improvement of VO₂max in both groups, but a statistically 
significant value in IG (Table I). 
Prevalence of “at risk” adolescents regarding each cardiometabolic marker can be 
observed in Table II. 
Correlations between changes in BMI and VO₂max and changes in body composition, 
metabolic variables, IR and oxidative and proinflammatory status are presented in Table 
III. 
It is noteworthy the significantly correlation between positive variations in BMI and 
increased WC, as also cardiometabolic risk factors (LDL-c and HOMA-IR) and a negative 
correlation with CRF (VO₂max) and adiponectin. Furthermore, an inverse association was 
observed for changes in VO₂max and adiposity markers (BMI, WC, LDL-c and ox-LDL). 
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DISCUSSION 
A major contributor to childhood obesity epidemic is lack of sufficient PA and that is why 
the engagement in PA and sport is a very important weapon in obesity prevention 
(Janssen et al., 2005, Hills et al., 2011). Physical education in schools is an effective public 
health initiative for promoting PA in children and youth but extra-school PA may be 
important for increasing PA and improving cardiometabolic risk factors and body 
composition in this population (Klakk et al., 2013, Cordova et al., 2012). A large proportion 
of adolescents do not follow the recommended PA guidelines and, although these are 
essential to avoid excess of BFM, besides MVPA, vigorous PA or extra recreational 
programs might have additional benefits in preventing obesity (Hills et al., 2011, Martinez-
Gomez et al., 2010, Calcaterra et al., 2013). 
The objective of this trial was to test the relation between exercise dose and IR, oxidative 
and proinflammatory status on obese adolescents while accessing anthropometric, 
metabolic variables and CRF. Initially there were 3 groups: CG, SG and AG. However, no 
significant difference in exercise dose was observed between SG and AG (different 
exercise groups), these were evaluated as an IG and compared to a CG (only performed 
school PA), corresponding to a moderate/intense exercise dose group and a low exercise 
dose group, respectively. 
All the participants in this trial were obese at baseline with no anthropometrics differences 
between groups (Table I). BMI and %BFM are widely used to access adiposity (Weber et 
al., 2013), but BMI alone is unable to make comparisons between overweight and obese 
children among groups of children. Alternatively, BMI z-sc was used to measure adiposity 
as it is age and gender specific and provides a continuous variable (Bell et al., 2007). 
17 
 
Exercise improves BMI z-sc in overweight and obese children and adolescents (Kelley et 
al., 2014). In agreement with this results, a significant reduction in BMI-zs was observed 
in IG, although adolescents maintained obese (BMI z-sc = 2.2±0.7) (Table I). BMI is a 
poor predictor of body fat as it does not differentiate between fat mass and fat-free mass 
(Wan et al., 2014). However, this can be executable with DXA that evaluates body 
composition. In this study, PA in IG was significantly associated with a decrease in %BFM 
and an increase of %FFM which is compatible with other similar studies that involve PA 
in obese adolescents (Farias et al., 2009). 
WC and WtHR are anthropometric predictors of central obesity associated with 
cardiometabolic risk (Mushtaq et al., 2011). It was observed a positive influence of PA on 
WC and WtHR in IG (Table I) with no statistically difference in CG. WC in adolescents is 
a well-known risk factor for MS and obese children with WC above the 90th percentile are 
at greater risk for developing dyslipidemia and IR than obese children without WC above 
this limit (Bassali et al., 2010). Although a significant reduction of WC occurred in IG, all 
participants maintained a WC above the 90th percentile, according to age and gender 
(Sardinha et al., 2012). The optimum cut-off for WtHR as a predictor of high 
cardiometabolic risk is still controversial in adolescent population (Mehta, 2014). In this 
trial it was used a cut-off of 0.50 and all sample at baseline was classified as having a 
high cardiometabolic risk (mean WtHR = 0.59), and after 6 months both groups 
maintained that high risk (mean WtHR CG = 0.59; mean WtHR IG = 0.55). 
Dyslipidemia is one of the most important co-morbidities in obese youth and it is 
characterized by low levels of HDL-c and high levels of TC, TG and LDL-c. Obesity plus 
an unfavorable lipid profile during pediatric age are the best predictors of risk of CVD 
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worldwide. Portuguese population has a high prevalence of obese progenitors as well as 
a high score of familiar dyslipidemia and therefore a possible genetic cause of 
dyslipidemia must be taken into account, other than obesity-related dyslipidemia (Rêgo, 
2008). In this study, after intervention, there was a significant improvement in TC, TG and 
LDL-c in IG. HDL-c increased at the end of intervention in both groups, being statistically 
different in the CG (Table I). 
Regular PA is considered a powerful weapon for glycemic control in obese population as 
well as reduction of co-morbidities associated to alterations of glucose metabolism and 
T2DM (Riddell and Iscoe, 2006). In this study, regarding the metabolism of glucose and 
insulin, no influence of PA on IR was observed in this trial. The only significant result was 
an increase in FPG in IG post-intervention. This result may be explained by the fact that 
the major puberty status in this group (T2-3 = 68.8%) is a stage that curses with 
physiologic IR. Even thus, it should be highlighted that HOMA-IR increased in CG whereas 
a slight reduction occurred in IG. There was no pre-diabetes risk as the baseline value of 
FPG of all sample was inferior to 100 mg/dL.  
Levels of oxidative stress and proinflammatory status have been found to be raised in 
children with obesity and features of MS, and are associated with the development of 
atherosclerosis and T2DM (Dennis et al., 2013, Buchan et al., 2014). It has been 
demonstrated that obese adolescents have higher levels of ox-LDL than normal weight 
peers and that ox-LDL is associated with IR after adjustment for body fatness (Norris et 
al., 2011). Other explored variable is adiponectin which was an adipose-derived protein 
with insulin-sensitizing and anti-inflammatory properties, being a protective hormone in 
obesity. Several studies showed that raised levels of CRP correlate with CVD risk factors, 
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including adiposity and blood pressure (Balagopal et al., 2011). One of the links between 
obesity and associated co-morbidities already mentioned is chronic low-grade systemic 
inflammation which was observed in the studied population at baseline (CRP between 
0.3-2.4). PA had a significant positive influence on ox-LDL and adiponectin in IG. This last 
adipocytokine also had a significant increase in CG suggesting a physiologic increment 
with age. Surprisingly, influence of PA on CRP was not established in this study. It is 
possible that longer intervention periods are necessary to achieve improvements in this 
inflammatory variable. 
CRF is the estimation of the global capability of the cardiovascular and respiratory 
systems to carry out sustained exercises (Calcaterra et al., 2013). Changes in CRF are 
largely influenced by PA, as it can be seen by a significant VO2 increase in IG post-
intervention. Obesity and low CRF have been shown to independently rise the risk of 
cardiovascular mortality, however in this trial all VO2 measures presented were above the 
cut-off value for low CRF. 
Low PA levels and low CRF have been associated with an elevated cluster of metabolic 
risk factors, not only in adults but also in youth. Recently, influence of PA on both fatness 
and fitness has been shown (Rizzo et al., 2007). This study, which involved a 6 month 
controlled recreational activity program with 3 times-weak of MVPA, demonstrated a 
significant inverse relation between the decrease of CRF and increasing BMI values 
(Table III). A better CRF was positively correlated with improvement of metabolic variables 
and oxidative and anti-inflammatory variables, as shown, respectively, by a decreased 
LDL-c, ox-LDL and increased adiponectin. Another important finding was the positive 
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correlation between changes in BMI and in IR (Table III). The absence of correlation 
between CRF and a decreased risk of IR may be due to the small sample size. 
One of the most important limitations of this study are the small sample size (n=44), but 
also the fact that family history of CVD was not accessed and that exercise dose was not 
robustly classified in the CG. Other limitation in accessing diabetes risk was the fact that 
IR was not measured by the gold standard method. 
Positive aspects rely on having a non-exercising obese CG, being a longitudinal study of 
considerable time (6 months) and the fact that various important variables linked to obesity 
were evaluated. 
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CONCLUSION 
Moderate-to-vigorous PA improved cardiovascular risk, oxidative and proinflammatory 
status and CRF in obese adolescents, but not diabetes risk. In Portugal, school-based PA 
programs show to be ineffective in reducing obesity and, an extra-curricular PA program, 
at least three times a week with MVPA, is mandatory as more effective in improving the 
aforementioned aspects that are extremely linked with obesity and that traduces a risk of 
development of CVD and T2DM. 
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Table I: 
Characteristics of the study sample at baseline and post-intervention: control 
(n=10) and intervention (n=34) groups 
Results are presented as mean (standard deviation) or median (interquartile range), unless otherwise indicated 
CA: Chronological age; BMI: Body mass Index; WC: waist circumference; WtHR: Waist to height ratio; BFM: Body fat mass; 
FFM: Fat-free Mass; TC: Total cholesterol; TG: Triglycerides; LDL-c: Low-density lipoprotein cholesterol; HDL-c: High density 
lipoprotein cholesterol; FPG: Fasting plasma glucose; FPI: Fasting plasma insulin; HOMA-IR: Homeostatic model assessment 
for insulin resistance; ox-LDL: oxidized low-density lipoprotein; CRP: C-reactive protein; VO₂max: maximal oxygen uptake 
p-values refer to longitudinal analyses (baseline vs post-intervention) within each group 
  
 
 
All Sample 
 
Control Group 
(n=10) 
Intervention Group 
(n=34) 
Baseline Baseline 
Post-
intervention 
p-Value Baseline 
Post-
intervention 
p-Value 
CA 
(years) 
10.7 (1.3) 10.6 (1.4) 11.2 (1.4) 0.004 10.8 (1.3) 11.3 (1.2) <0.001 
Height 
(z-score) 
1.1 (1.1) 2.0 (1.3) 1.7 (1.3) 0.003 0.9 (0.9) 0.7 (0.9) <0.001 
BMI 
(z-score) 
2.5 (0.7) 2.9 (0.6) 2.8 (0.6) 0.167 2.4 (0.7) 2.2 (0.7) <0.001 
WC 
 
88.2 (10.4) 93.1 (10.2) 92.5 (10.7) 0.690 86.7 (10.1) 82.7 (9.8) <0.001 
WtHR 0.59 (0.06) 0.60 (0.06) 0.59 (0.06) 0.343 0.58 (0.06) 0.55 (0.06) <0.001 
BFM (%) 35.3 (7.3) 34.6 (6.6) 39.1 (10.6) 0.047 35.4 (7.5) 32.2 (8.5) <0.001 
FFM (%) 36.9 (8.3) 43.6 (9.2) 41.4 (9.5) 0.220 35.0 (7.0) 36.9 (7.6) <0.001 
Tanner Stage 
[n(%)] 
T1 13 (29.5) 
T2-3 27 (61.4) 
T4-5 4 (9.1) 
T1 2 (20) 
T2-3 7 (70) 
T4-5 1 (10) 
T1 0 (0) 
T2-3 9 (90)) 
T4-5 1 (10) 
0.168 
T1 11 (32.4) 
T2-3 20 (58.8) 
T4-5 3 (8.8) 
T1 9 (26.5) 
T2-3 21 (61.7) 
T4-5 4 (11.8) 
0.003 
TC (mg/dL) 167.2 (34.3) 170.3 (21.1) 171.3 (25.7) 0.854 166.3 (37.5) 155.2 (29.7) 0.002 
TG (mg/dL) 80.6 (43.6) 81.0 (45.0) 72.3 (34.1) 0.440 80.5 (43.9) 60.9 (22.0) 0.001 
LDL-c (mg/dL) 100.9 (33.2) 107.6 (19.6) 106.4 (27.5) 0.800 98.9 (36.2) 88.5 (29.6) 0.004 
HDL-c (mg/dL) 50.5 (10.7) 46.5 (8.9) 50.4 (9.4) 0.010 51.6 (11.1) 54.5 (13.0) 0.064 
FPG (mg/dL) 82.8 (6.2) 85.6 (8.0) 83.1 (9.3) 0.330 82.0 (5.4) 85.9 (6.8) 0.002 
FPI (µU/mL) 10.3 (5.7-11.5) 9.3 (5.9-12.1) 11.5 (9.2-15.9) 0.285 10.3 (5.5-11.2) 7.6 (5.8-11.3) 0.739 
HOMA-IR 1.9 (1.1-2.4) 1.8 (1.3-2.7) 2.4 (2.0-3.2) 0.285 1.9 (1.0-2.4) 1.8 (1.2-2.9) 0.326 
ox-LDL (U/L) 58.5 (19.6) 65.1 (16.4) 61.9 (15.4) 0.296 56.5 (20.3) 50.5 (16.3) <0.001 
Adiponectin 
(µg/mL) 
9.8 (4.1) 9.0 (2.2) 10.6 (2.7) 0.057 10.5 (4.7) 14.4 (6.4) <0.001 
CRP (mg/L) 0.7 (0.3-2.4) 0.9 (0.6-1.4) 0.8 (0.3-1.9) 0.878 0.6 (0.3-3.1) 0.7 (0.4-2.4) 0.521 
VO₂max 
(mlO₂/min/Kg) 
44.3 (9.5) 45.0 (12.9) 46.6 (18.8)) 0.933 44.1 (8.7) 49.6 (7.4) <0.001 
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Table II: 
Prevalence of “at risk” adolescents, regarding cardiometabolic risk factors within 
control and intervention groups 
 
Values presented as n (%) 
“At risk” was defined as: TC≥ 200 mg/dl or LDL-c ≥ 130 mg/dl or TG≥ 150 mg/dl or HDL-c ≤ 35 mg/dl or HOMA IR ≥ 2.67 and 
5.22 for pre- and pubertal adolescents 
TC: Total cholesterol; TG: Triglycerides; LDL-c: Low-density lipoprotein cholesterol; HDL-c: High density lipoprotein 
cholesterol; HOMA-IR: Homeostatic model assessment for insulin resistance 
  
 Control Group 
(n=10) 
Intervention Group 
(n=34) 
Baseline Post-intervention Baseline Post-intervention 
TC 1 (10) 1 (10) 5 (15) 3 (9) 
TG 1 (10) 0 (0) 2 (6) 0 (0) 
LDL-c 1 (10) 2 (20) 4 (12) 3 (9) 
HDL-c 1 (10) 0 (0) 3 (9) 1 (3) 
HOMA-IR 1 (10) 1 (10) 1 (3) 1 (3) 
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Table III: 
Correlations between changes in BMI and VO₂max and changes in body 
composition, metabolic variables and oxidative and proinflammatory status 
 
 
 Δ BMI Δ VO₂ max 
r p-value r p-value 
Δ BMI --- --- -0.339 0.032 
Δ WC 0.588 <0.001 -0.327 0.040 
Δ LDL-c 0.337 0.025 -0.317 0.046 
Δ HOMA-IR 0.335 0.026 -0.063 0.700 
Δ ox-LDL 0.253 0.098 -0.321 0.004 
Δ adiponectin -0.432 0.003 0.392 0.012 
 
Δ were calculated as the difference between post-intervention and pre-intervention measures for all sample (n=44) 
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manuscript. Each table and/or figure must have a legend that explains its purpose without reference 
to the text.  
 
Tables should be used only when they can present information more efficiently than running text. 
Care should be taken to avoid any arrangement that unduly increases the depth of a table, and the 
column heads should be made as brief as possible, using abbreviations liberally. Lines of data should 
not be numbered nor run numbers given unless those numbers are needed for reference in the text. 
Columns should not contain only one or two entries, nor should the same entry be repeated 
numerous times consecutively. Tables should be grouped at the end of the manuscript on separate 
pages. 
 
Figures/Illustrations (line drawings, halftones, photos, photomicrographs, etc.) should be submitted as 
digital files for highest quality reproduction and should follow these guidelines: 
 
 300 dpi or higher 
 Sized to fit on journal page 
 EPS, JPG, TIFF, or PSD format only 
 Submitted as separate files, not embedded in the text 
 Legends or captions for figures should be listed on a separate page, double spaced 
 
For information on submitting animations, movie files and sound files or any additional information 
including indexes and calendars please click here. 
 
For information on colour figures and charges please click here 
 
Notes on Style 
 
General Style 
Authors are asked to take into account the diverse audience of the journal. Please avoid the use of 
terms that might be meaningful only to a local or national audience, or provide a clear explanation 
where this is unavoidable. Some specific points on style follow: 
 
1. Authors should write in clear, concise English. If this is not your native language please ensure 
the manuscript has been reviewed by a native speaker. Please note: extensive rewriting of the 
text will not be undertaken by the editorial staff. 
2. Acronyms for protein and gene names should in all cases be explained the first time they 
appear. In articles where acronyms are numerous, authors should include a table that lists all 
acronyms, each acronym’s meaning or origin, and a short description of the function of each 
gene or protein. 
3. Latin terminology, including microbiological and species nomenclature, should be italicized. 
4. Use standard convention for human and animal genes and proteins: italics for genes and 
regular font for proteins, and upper case for human products and lower case for animal 
products. 
5. “US” is preferred to “American”, “USA” to “United States”, and “UK” to “United Kingdom”. 
6. Double quotation marks rather than single are to be used unless the “quotation is ‘within’ 
another”. 
7. Punctuation of common abbreviations should adhere to the following conventions: “e.g.”; “i.e.”; 
“cf.”. Note that such abbreviations should not generally be followed by a comma or a (double) 
point/period. 
8. Upper case characters in headings and references should be used sparingly, e.g. only the first 
word of paper titles, subheadings and any proper nouns begin upper case; similarly for the titles 
of papers from journals in the references and elsewhere. 
9. Apostrophes should be used sparingly. Thus, decades should be referred to as follows: “The 
1980s [not the 1980’s] saw …”. Possessives associated with acronyms (e.g. APU), should be 
written as follows: “The APU’s findings that …” but note that the plural is “APUs”. 
10. All acronyms for national agencies, examinations, etc., should be spelled out the first time they 
are introduced in text or references. Thereafter the acronym can be used if appropriate, e.g. 
“The work of the Assessment of Performance Unit (APU) in the early 1980s …” and 
subsequently, “The APU studies of achievement …”, in a reference “(Department of Education 
and Science [DES] 1989a)”. 
11. Brief biographical details of significant national figures should be outlined in the text unless it is 
quite clear that the person concerned would be known internationally. Some suggested editorial 
comments in a typical text are indicated in the following with square brackets: “From the time of 
H. E. Armstrong [in the 19th century] to the curriculum development work associated with the 
Nuffield Foundation [in the 1960s], there has been a shift from constructivism to heurism in the 
design of [British] science courses”. 
12. Non-discriminatory language is mandatory. Sexist or racist terms should not be used. 
13. The referred local (national) usage for ethnic and other minorities should be used in all papers. 
For the USA, “African-American”, “Hispanic” and “Native American” are used, e.g. “The African-
American presidential candidate, Jesse Jackson …”; for the UK, “Afro-Caribbean” (not “West 
Indian”), etc. 
14. Material to be emphasised by italicisation in the printed version should be italicised in the 
typescript rather than underlined. Please use such emphasis sparingly. 
15. Numbers in text should take the following forms: 300, 3000, 30 000 (not 30,000). Spell out 
numbers under 10 unless used with a unit of measure, e.g. nine pupils but 9 mm (do not use 
full stops (periods) within units). For decimals, use the form 0.05 (not .05, × 05 or 0× 05). “%” 
(not “per cent”) should be used in typescripts. 
16. Authors must adhere to SI Units 
17. Appendices should appear before the references section and after any acknowledgments 
section. The style of the title is shown by the following example: 
“Appendix C: The random network generator”. 
Figures and tables within appendices should continue the sequence of numbering from the 
main body of the text. Sections within appendices should be numbered, for example, C.1, C.2. 
Equations in appendices should be numbered, for example, (C 1), (C 2). If there is only one 
appendix, it is referred to as “the appendix” and not called “Appendix A”. 
 
Abbreviations and nomenclature 
For abbreviations and nomenclature, authors should consult the most recent edition of the CSE Style 
Manual available from the Council of Science Editors, 60 Revue Drive, Suite 500 Northbrook, IL, 
60062, USA. 
 
Mathematics 
Please click here for more information on the presentation of mathematical text. 
 
Footnotes 
Footnotes are not to be used except for designation of the corresponding author of the paper or 
current address information for an author (if different from that shown in the affiliation). Information 
concerning grant support of reviews should appear in a separate declaration of interest section at the 
end of the paper. Acknowledgments of the assistance of colleagues or similar notes of appreciation 
belong in a separate Acknowledgments section. 
 
Footnotes to tables should be typed directly below the table and are indicated by the following 
symbols: * (asterisk or star), † (dagger), ‡ (double dagger), ¶ (paragraph mark), § (section mark), || 
(parallels), # (number sign). Reinitialize symbol sequence within tables. 
 
Editorial Policies 
Authorship 
Anyone meeting the International Committee on Medical Journal Ethics (ICJME) requirements for 
authorship should be included as an author of the manuscript and anyone designated as an author 
should meet all points of the ICJME criteria for authorship. Any other form of specific personal 
contribution should be included in the Acknowledgements section of the manuscript, which must be 
provided under the subheading ‘Acknowledgements’. All submissions are expected to comply with the 
ICMJE authorship definition. Changes to the authorship list after submission will result in a query from 
the publisher requesting written explanation. 
Redundant publications and plagiarism 
Annals of Human Biology considers all manuscripts on the strict condition that they have not been 
published already, nor are they under consideration for publication or in press elsewhere. 
 
Annals of Human Biology will not consider, in general, redundant publications, i.e. “publication of a 
paper that overlaps substantially with one already published in print or electronic media” (International 
Committee on Publication Ethics: http://www.icmje.org/publishing_4overlap.html). This rule applies 
whether the overlapping papers are from the same authors or not. 
In addition, Informa has a strict policy against plagiarism. We define plagiarism as the use of extracts 
from another person's work that are not placed in quotation marks, without the permission of that 
person, and without acknowledgement to that person (using the appropriate reference style), with the 
result that your article presents these extracts as original to you. By submitting your work to an 
Informa Healthcare journal, you warrant that it is your original work, and that you have secured the 
necessary written permission from the appropriate copyright owner or authority for the reproduction of 
any illustration or other material. 
Paraphrasing, defined as “taking portions of text from one or more sources, crediting the author/s, but 
only changing one or two words or simply rearranging the order, voice (i.e., active vs. passive) and/or 
tense of the sentences” by the US Office on Research Integrity 
(http://ori.dhhs.gov/education/products/plagiarism/7.shtml), will not be accepted if found to be used 
extensively and to make up large sections of the manuscript. Extensive paraphrasing will not be 
deemed original work and will be viewed as redundant publication and/or plagiarism. 
Informa Healthcare adheres to the Code of Conduct and Best Practice Guidelines set forth by the 
Committee on Publication Ethics (COPE). As per these guidelines, failure to adhere to the above 
conditions will result in the editor and Informa publishing an appropriate correction, a statement of 
retraction, or enacting a withdrawal of the article. In extreme cases (e.g. when an article is retracted), 
offending authors will be reported to their institution’s Ethics committee and may be banned from 
submitting to Informa Healthcare journals in the future. Please refer to the COPE website for the 
detailed workflows for handling allegations of plagiarism or redundant publication 
(http://www.publicationethics.org/resources/flowcharts). 
Inclusion of Unpublished Data 
Unpublished data in the form of figures, tables, or quantitative statements in the text, should not be 
included in an article under any circumstances. A brief mention of the tentative conclusions of 
unpublished work is sometimes acceptable, as long as it is clearly identified as unpublished and 
tentative (not yet peer-reviewed). 
Peer Review 
 
All manuscripts will be subjected to confidential peer review by experts in the field and, on the basis of 
reviewers’ feedback, papers will be accepted unconditionally, accepted subject to revision, rejected 
with an option to resubmit or rejected. 
 
Ethics and Consent   
Papers including human subject research, animal experiments or clinical trials must be conducted 
with approval by the local animal care or human subject committees, respectively. All manuscripts, 
except reviews, must include a statement in the Introduction or Methods section that the study was 
approved by an Investigational Review Board (Human Studies Committee or Ethics Committee or 
Animal Care and Use Committee), if applicable, and whether written informed consent was obtained. 
Authors who do not have formal ethics review committees should include a statement that their study 
followed principles in the Declaration of Helsinki (http://www.wma.net/e/policy/b3.htm).. 
Do not use patients' names, initials, or hospital numbers, especially in illustrative material. Identifying 
information should not be published in written descriptions, photographs, and pedigrees unless the 
information is essential for scientific purposes and the patient (or parent or guardian) gives written 
informed consent for publication. Informed consent for this purpose requires that the patient be shown 
the manuscript to be published. 
 
To comply with FDAAA legislation, Informa Healthcare requires trial registration as a condition of 
publication for all studies involving clinical trials. Trial registration numbers should be included in the 
abstract, with full details provided in the methods section. 
 
When a product has not yet been approved by an appropriate regulatory body for the use described in 
the manuscript, the author must specify that the product is not approved for the use under discussion 
or that the product is still under investigation. 
 
Further information on Ethics and Consent can be found by clicking here 
Copyright and Permissions 
 
It is a condition of publication that authors assign copyright or license the publication rights in their 
articles, including abstracts, to Informa UK Ltd. This enables us to ensure full copyright protection and 
to disseminate the article, and the Journal, to the widest possible readership in print and electronic 
formats as appropriate.  
 
Authors are required to sign an agreement for the transfer of copyright to the publisher. All accepted 
manuscripts, artwork, and photographs become the property of the publisher. A copyright agreement 
form can be downloaded by corresponding authors of accepted manuscripts with proofs. This should 
be signed and returned to InformaHealthcare. 
 
Authors are themselves responsible for obtaining permission to reproduce copyright material from 
other sources. 
 
Further information on Permissions can be found by clicking here. 
Declaration of Interest 
 
It is the policy of InformaHealthcare to adhere in principle to the Conflict of Interest policy 
recommended by the ICMJE. All authors must disclose any financial and personal relationships with 
other people or organizations that could inappropriately influence (bias) their work. It is the sole 
responsibility of authors to disclose any affiliation with any organization with a financial interest, direct 
or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, 
employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or 
ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of 
the work submitted. All sources of funding for reviews are to be explicitly stated. If uncertain as to 
what might be considered a potential conflict of interest, authors should err on the side of full 
disclosure. 
 
If there are no declarations, authors should explicitly state that there are none. This must be stated at 
the point of submission (within the manuscript, after the main text, under a subheading "Declaration of 
interest", and within the appropriate field on the journal's Manuscript Central site).  Manuscript 
submission cannot be completed unless a declaration of interest statement (either stating the 
disclosures or reporting that there are none) is included. 
 
This will be made available to reviewers and will appear in the published article. If any potential 
conflicts of interest are found to have been withheld following publication, the journal will proceed 
according to COPE guidance. 
 
The intent of this policy is not to prevent authors with any particular relationship or interest from 
publishing their work, but rather to adopt transparency such that reviewers, editors, the publisher, and 
most importantly, readers can make objective judgements concerning the work product. 
 
iOpenAccess  
 
All authors whose manuscripts are accepted for publication have the option to make their article freely 
available to all via the journal's website, for a one-off fee of $3737.50. This initiative, known as 
iOpenAccess, is a 'hybrid' open access scheme, and comes after the experience of a number of 
years' experimentation with access schemes operated by various Informa Healthcare and T&F 
journals, as well as wide consultation with our editors, society partners and research funders. If an 
author chooses to opt for iOpenAccess: 
 
 The article can be freely posted to any institutional or subject repository. Authors selecting the 
iOpenAccess option will have no embargo restriction on posting their version of the published 
article to any institutional or subject repository. Where appropriate, Informa Healthcare will 
also facilitate the deposit on behalf of authors into PubMedCentral (please see 'NIH Public 
Access Policy', below). 
 
 The article will be freely accessible to all. Authors will be asked to grant a publishing license 
or assign copyright in the normal way. Selection of the iOpenAccess option and payment of 
the appropriate fee will then allow the article to be made available to all. Under the publishing 
license Informa will allow tagging and cross-referencing of articles within repositories so that 
they relate back to the original research grants and programs. 
 
 The peer review integrity of the article will not be compromised. Informa Healthcare's 
commitment to stringent, independent, expert peer review remains: only accepted articles are 
eligible for the scheme, and authors will only be offered the open access option when they are 
sent their proofs for review. This complete separation of payment from the peer review and 
acceptance process will ensure that editorial independence and quality are not compromised. 
 
NIH/Wellcome Public and Open Access Policies 
 
In consideration of the National Institutes of Health (NIH) and Wellcome Public and Open Access 
Policies, Informa Pharmaceutical Science acknowledges that the broad and open dissemination of 
NIH/Wellcome-funded research results may benefit future scientific and medical research. Because 
we value the current and future contributions our journals make to the scientific body of knowledge, 
we have made certain that our policies accommodate those authors who wish to submit to PubMed 
Central. 
 
As part of our author services programme, Informa Healthcare will deposit to PubMed Central (PMC) 
and UK PubMed Central (UKPMC) author manuscripts reporting NIH or Wellcome Trust funded 
research in the Acknowledgments section. 
 
This service will help authors to comply with the NIH and Wellcome Trust revised 'Public Access 
Policy' and ‘Open Access Policy’, respectively. 
 
NIH policy 
NIH-funded authors must submit to PMC, or have submitted on their behalf, at the point of 
acceptance, their peer-reviewed author manuscripts, to appear on PMC no later than 12 months after 
final publication. 
 
Click here for more information. 
 
Wellcome Trust policy 
Wellcome-funded authors must submit to UKPMC, or have submitted on their behalf, at the point of 
acceptance, their peer-reviewed author manuscripts, to appear on UKPMC no later than 6 months 
after final publication. 
 
Click here for more information. 
 
Informa Healthcare will deliver to PMC/UKPMC the final peer-reviewed manuscript, which was 
accepted for publication and that reflects any author-agreed changes made in response to the peer 
review. We will also authorise the public access posting of author manuscripts 12 months (NIH) or 6 
months (Wellcome Trust) after final publication in print or electronic form (whichever is the sooner). 
Following the deposit, authors will receive further communications from the NIH Manuscript 
Submission System/UK Manuscript Submission System with respect to the submission. 
 
Under our Author Rights policy, authors also have the right to post their version of the submitted 
author manuscript (pre-print), or their version of the final published article (post-print) on their personal 
or institutional web site. Post-print web postings are subject to an embargo of 12 months. This 
embargo period begins the day the work is published online at www.informahealthcare.com.  
 
Please note that authors should not post manuscripts directly to PMC/UKPMC or other third party 
sites for any systematic external distribution by a third party (e.g., to a listserv or database connected 
to a public access server). 
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Proofs 
 
Usual practice will involve corresponding authors receiving email notification with a password and 
web address from which to download a PDF. Hard copies of proofs will not be mailed. To avoid 
delays in publication, corrections to proofs must be returned within 48 hours, by electronic transmittal, 
fax or mail. Authors will be charged for excessive correction at this stage of production. If authors do 
not return page proofs promptly, the Publisher reserves the choice to either delay publication to a 
subsequent issue or to proceed to press without author corrections. The Publisher reserves the right 
to proceed to press without submitting page proofs to the author. 
Reprints 
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individual articles are available for order at the time authors review page proofs. A discount on 
reprints is available to authors who order before print publication. Copies of the journal can be 
purchased at the author’s preferential rate of $25/£15 per copy. 
 
Further information on Reprints can be found by clicking here. 
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